Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02365714 · ClinicalTrials.gov registry record · Phase 1
CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)
A Phase 1 study, sponsored by Georgetown University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT02365714 is a Phase 1 study that was terminated before completion, run by Georgetown University. The registered enrollment target is 2 participants.
The verdict
NCT02365714, a Phase 1 study, was terminated before completion, sponsored by Georgetown University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study will prospectively evaluate the technical feasibility, acute toxicity, late effects and oncologic outcomes of CyberKnife Stereotactic Accelerated Partial Breast Irradiation (CK-SAPBI) in early stage breast cancer. It will evaluate quality of life (QOL) issues as they relate to treatment-related side effects and cosmetic results.
Interventions
- RADIATION CK Stereotactic Accelerated Partial Breast Irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02365714
The ClinicalTrials.gov registry entry for NCT02365714 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CK Stereotactic Accelerated Partial Breast Irradiation is the first listed.
NCT02365714 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02365714 about?
NCT02365714 is a clinical study titled "CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)". This study will prospectively evaluate the technical feasibility, acute toxicity, late effects and oncologic outcomes of CyberKnife Stereotactic Accelerated Partial Breast Irradiation (CK-SAPBI) in early stage breast cancer. It will evaluate quality of life (QOL) issues as they relate to treatment-r...
What is the current status of trial NCT02365714?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2015-02. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02365714?
The interventions under investigation include: CK Stereotactic Accelerated Partial Breast Irradiation (RADIATION).
Who is sponsoring clinical trial NCT02365714?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.